{"id":58665,"date":"2024-01-03T22:05:11","date_gmt":"2024-01-03T21:05:11","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/align-technology-completes-acquisition-of-cubicure-a-pioneer-of-direct-3d-printing-solutions-for-polymer-additive-manufacturing\/"},"modified":"2024-01-03T22:05:11","modified_gmt":"2024-01-03T21:05:11","slug":"align-technology-completes-acquisition-of-cubicure-a-pioneer-of-direct-3d-printing-solutions-for-polymer-additive-manufacturing","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/align-technology-completes-acquisition-of-cubicure-a-pioneer-of-direct-3d-printing-solutions-for-polymer-additive-manufacturing\/","title":{"rendered":"Align Technology Completes Acquisition of Cubicure, a Pioneer of Direct 3D Printing Solutions for Polymer Additive Manufacturing"},"content":{"rendered":"
\n

\nAlign continues to innovate and invest in technologies that enable the next generation of direct 3D printed products, thus helping us create more sustainable and efficient solutions.<\/b><\/p>\n

SAN JOSE, Calif. & TEMPE, Ariz. & VIENNA–(BUSINESS WIRE)–Align Technology, Inc. (Align) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign\u00ae system of clear aligners, iTero\u2122 intraoral scanners, and exocad\u2122 CAD\/CAM software for digital orthodontics and restorative dentistry, today announced that it has completed the acquisition of privately-held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing that develops, produces, and distributes innovative materials, equipment, and processes for novel 3D printing solutions.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe acquisition of Cubicure will support and scale Align\u2019s strategic innovation roadmap and strengthen the Align Digital Platform\u2122. Cubicure will also extend and scale Align\u2019s printing, materials, and manufacturing capabilities for our 3D printed product portfolio which now includes the Invisalign\u00ae Palatal Expander system, Align\u2019s first direct 3D printed orthodontic device and a safe, comfortable, and clinically effective* alternative to traditional palatal expanders. Cubicure\u2019s patented Hot Lithography technology uses a special heating and coating mechanism that enables the processing of highly viscous resins to produce particularly tough and temperature-resistant polymers. This high precision 3D printing process facilitates the unprecedented additive manufacturing of resilient components with an astonishing first of its kind material quality performance.<\/p>\n

\nCommenting on today\u2019s announcement, Joe Hogan, Align Technology president and CEO said, \u201cThe acquisition of Cubicure brings a talented team and unique cutting-edge technology into Align and will enable us to scale our 3D printing operations to eventually direct print millions of custom appliances per day. Direct 3D printing enables Align to create 3D printed solutions without the added step of first creating a mold, making 3D printing more sustainable and efficient. I am excited to take this important step in our relationship with Cubicure, which began several years ago as a joint development program.\u201d<\/p>\n

\n\u201cAlign has invested billions of dollars on innovation over the past 27 years, including next-generation 3D printing technologies to process high-performance polymers,\u201d said Srini Kaza, Align senior vice president, product research & development. \u201cWe\u2019ve been working with Cubicure for years and I am thrilled that they are now officially employees of Align and members of our R&D organization. We’re at the beginning of this next wave of direct 3D printing additive manufacturing and I believe we’re poised to transform the orthodontic industry again with our unprecedented ability to direct print devices.\u201d<\/p>\n

\nThe acquisition closed on January 2, 2024, for approximately \u20ac79 million subject to final closing adjustments and adjustments for Align\u2019s existing ownership of capital stock of Cubicure.<\/p>\n

\n*Based on a survey in August 2023 in Canada of 10 Invisalign trained orthodontists who participated in the Invisalign Palatal Expander System Technical Design Assessment and have treated at least 1 patient age 6-11 years with IPE. Data on file at Align Technology, Inc. as of October 30, 2023.<\/p>\n

\nAbout Align Technology, Inc.<\/span><\/b><\/p>\n

\nAlign Technology designs and manufactures the Invisalign\u00ae system, the most advanced clear aligner system in the world, iTero\u2122 intraoral scanners and services, and exocad\u2122 CAD\/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 252 thousand doctor customers and are key to accessing Align\u2019s 600 million consumer market opportunity worldwide. Over the past 26 years, Align has helped doctors treat over 16.4 million patients with the Invisalign system and is driving the evolution in digital dentistry through the Align Digital Platform\u2122, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab\/partners. Visit www.aligntech.com<\/a> for more information.<\/p>\n

\nFor additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com<\/a>. For additional information about the iTero digital scanning system, please visit www.itero.com<\/a>. For additional information about exocad dental CAD\/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com<\/a>.<\/p>\n

\nInvisalign, iTero, exocad, Align, and Align Digital Platform are trademarks of Align Technology, Inc.<\/p>\n

\nForward-Looking Statements<\/span><\/b><\/p>\n

\nThis news release and other information publicly disseminated by us, contains forward-looking statements, including statements of beliefs and expectations regarding expected transaction benefits and synergies as a result of the acquisition, our 3D printing operations and products, and other matters discussed in this press release that are not purely historical data. We do not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Forward-looking statements contained in this news release relating to expectations about future events or results are based upon information available to Align as of the date hereof. Readers are cautioned that these forward-looking statements reflect our best judgments based on currently known facts and circumstances and are subject to risks, uncertainties, and assumptions that are difficult to predict. As a result, actual results may differ materially and adversely from those expressed in any forward-looking statements.<\/p>\n

\nFactors that might cause such a difference include, but are not limited to:<\/p>\n